MARC

LEADER 00000cam a2200000 i 4500
001 EBSCO_on1162501962
003 OCoLC
005 20231017213018.0
006 m o d
007 cr |||||||||||
008 090701s2010 nyu ob 001 0 eng
010 |a  2020687676 
040 |a DLC  |b eng  |e rda  |c DLC  |d VLY  |d OCLCO  |d N$T  |d YDXCP  |d E7B  |d OCLCF  |d NLGGC  |d EBLCP  |d AZK  |d TOA  |d AGLDB  |d MOR  |d PIFAG  |d ZCU  |d MERUC  |d U3W  |d STF  |d WRM  |d VTS  |d COCUF  |d NRAMU  |d ICG  |d VT2  |d AU@  |d WYU  |d REC  |d DKC  |d UX1  |d UKCRE  |d AJS  |d OCLCA  |d OCLCO  |d OCLCQ  |d OCLCO 
015 |a GBA989095  |2 bnb 
016 7 |a 101509708  |2 DNLM 
016 7 |a 015366678  |2 Uk 
019 |a 692204893  |a 923661713  |a 961571085  |a 962651982  |a 988515593  |a 992113666  |a 1037937070  |a 1038675363  |a 1045507767  |a 1055340443  |a 1058994244  |a 1065693783  |a 1081222764  |a 1097150393  |a 1153520207 
020 |a 9781616687229  |q (ebook) 
020 |a 1616687223 
020 |z 9781608760510  |q (hardcover) 
020 |z 1608760510 
029 1 |a AU@  |b 000048636225 
029 1 |a AU@  |b 000051358289 
029 1 |a DEBBG  |b BV043121766 
029 1 |a DEBBG  |b BV044088567 
029 1 |a DEBSZ  |b 421659548 
029 1 |a NZ1  |b 15346707 
029 1 |a AU@  |b 000060546773 
035 |a (OCoLC)1162501962  |z (OCoLC)692204893  |z (OCoLC)923661713  |z (OCoLC)961571085  |z (OCoLC)962651982  |z (OCoLC)988515593  |z (OCoLC)992113666  |z (OCoLC)1037937070  |z (OCoLC)1038675363  |z (OCoLC)1045507767  |z (OCoLC)1055340443  |z (OCoLC)1058994244  |z (OCoLC)1065693783  |z (OCoLC)1081222764  |z (OCoLC)1097150393  |z (OCoLC)1153520207 
042 |a pcc 
050 0 0 |a RC776.O3 
060 0 0 |a 2010 G-384 
060 1 0 |a WF 600  |b C781 2010 
072 7 |a MED  |x 079000  |2 bisacsh 
082 0 0 |a 616.2/4  |2 22 
049 |a UAMI 
245 0 0 |a COPD is/is not a systemic disease? /  |c Claudio F. Donner, editor. 
264 1 |a New York :  |b Nova Biomedical Books,  |c [2010] 
300 |a 1 online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Public health in the 21st century series 
504 |a Includes bibliographical references and index. 
588 |a Description based on print version record. 
546 |a English. 
505 0 |a INTRODUCTION; COPD IS A SYSTEMIC DISEASE -- THE PATHPHYSIOLOGICAL BASIS; COPD IS NOT A SYSTEMIC DISEASE -- THE PATHOPHYSIOLOGICAL BASIS; DISCUSSION ON THE PATHOPHYSIOLOGICAL BASIS OF COPD; COPD AND SYSTEMIC INFLAMMATION: MYTH OR REALITY? REALITY; COPD AND SYSTEMIC INFLAMMATION: MYTH OR REALITY? MYTH; DISCUSSION ON COPD AND SYSTEMIC INFLAMMATION: MYTH OR REALITY?; BIOMARKERS OF SYSTEMIC INVOLVEMENT IN STABLE COPD: DO THEY EXIST? YES; BIOMARKERS OF SYSTEMIC INOLVEMENT IN STABLE COPD: DO THEY EXIST? NO; DISCUSSION ON BIOMARKERS OF SYSTEMIC INVOLVEMENT IN STABLE COPD: DO THEY EXIST? 
505 8 |a DISCUSSION IN-DEPTH OF TOPICS PRESENTED IN THE MORNING, WITH A VIEW TO REACHING A CONSENSUS OR DISSENSUSBIOMARKERS OF SYSTEMIC INVOLVEMENT IN ACUTE EXACERBATIONS OF COPD: IS THERE OVERWHELMING EVIDENCE? YES; IS THERE EVIDENCE FROM BIOMARKERS OF SYSTEMIC INVOLVEMENT IN COPD EXACERBATIONS? NO; DISCUSSION ON: IS THERE OVERWHELMING EVIDENCE FROM BIOMARKERS OF SYSTEMIC INVOLVEMENT IN COPD EXACERBATIONS?; SCIENCE AT THE BEDSIDE. IS COPD A RESPIRATORY DISEASE WITH PROMINENT SYSTEMIC IMPLICATIONS OR A SYSTEMIC DISEASE WITH PULMONARY SYMPTOMS? 
505 8 |a DISCUSSION ON: IS COPD A RESPIRATORY DISEASE WITH PROMINENT SYSTEMIC IMPLICATIONS OR A SYSTEMIC CONDITION WITH PULMONARY SYMPTOMS?APPROACH TO COPD: RESPIRATORY OR SYSTEMIC TREATMENT? RESPIRATORY APPROACH; APPROACH TO COPD: RESPIRATORY OR SYSTEMIC TREATMENT? SYSTEMIC APPROACH; DISCUSSION ON THE APPROACH TO COPD: RESPIRATORY OR SYSTEMIC TREATMENT?; GUIDELINES AND CLINICAL PRACTICE: MYTH OR REALITY? -- MYTH; GUIDELINES AND CLINICAL PRACTICE: MYTH OR REALITY? -- REALITY; DISCUSSION ON: GUIDELINES AND CLINICAL PRACTICE: MYTH OR REALITY? 
505 8 |a DISCUSSION IN-DEPTH OF TOPICS PRESENTED IN THE AFTERNOON, WITH A VIEW TO REACHING A CONSENSUS OR DISSENSUSSUMMING UP AND FINAL REMARKS; INDEX. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Lungs  |x Diseases, Obstructive. 
650 0 |a Lungs  |x Diseases, Obstructive  |x Complications. 
650 0 |a Inflammation. 
650 1 2 |a Pulmonary Disease, Chronic Obstructive  |x physiopathology 
650 2 |a Inflammation 
650 6 |a Poumons  |x Maladies obstructives. 
650 6 |a Poumons  |x Maladies obstructives  |x Complications et séquelles. 
650 6 |a Inflammation (Pathologie) 
650 7 |a MEDICAL  |x Pulmonary & Thoracic Medicine.  |2 bisacsh 
650 7 |a Inflammation  |2 fast 
650 7 |a Lungs  |x Diseases, Obstructive  |2 fast 
650 7 |a Lungs  |x Diseases, Obstructive  |x Complications  |2 fast 
700 1 |a Donner, C. F.  |q (Claudio F.),  |e editor. 
776 0 8 |i Print version:  |t COPD is/is not a systemic disease?  |d New York : Nova Biomedical Books, [2010]  |z 1608760510 (hardcover)  |w (DLC) 2009027333 
830 0 |a Public health in the 21st century series. 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=347484  |z Texto completo 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL3019991 
938 |a ebrary  |b EBRY  |n ebr10674999 
938 |a EBSCOhost  |b EBSC  |n 347484 
938 |a YBP Library Services  |b YANK  |n 3568551 
994 |a 92  |b IZTAP